Sinopharm, Sinovac vaccines prevent severe hospitalization from Omicron: report

2022-01-06 00:54:44Xinhua Editor : Wang Fan ECNS App Download

China's Sinopharm and Sinovac COVID-19 vaccines protect against "severe hospitalization" caused by the Omicron variant, the United Arab Emirates-based news outlet The National reported Tuesday, quoting a World Health Organization (WHO) expert as saying.

Abdi Mahamud, the WHO's incident manager for the pandemic, said that "more evidence is showing that Omicron is affecting the upper respiratory tract, causing milder symptoms than previous variants."

The UAE recently approved the emergency use of a new recombinant protein vaccine manufactured by Sinopharm, which will be used as a booster jab in the country, the report said.

The new Chinese vaccine demonstrated an improved immune capacity against the new variant, "with a high safety rate that allows rapid production and easy storage and distribution," according to the UAE's health ministry.


Most popular in 24h

MoreTop news


Back to top About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2022 All rights reserved.
Reproduction in whole or in part without permission is prohibited.
[网上传播视听节目许可证(0106168)] [京ICP证040655号]
[京公网安备 11010202009201号] [京ICP备05004340号-1]